FDA Announces Hearing on Genetically Engineered Salmon Labeling
The Food and Drug Administration is announcing a public hearing on September 21, 2010 in Rockville, MD regarding the labeling of food derived from AquAdvantage Salmon, a genetically engineered Atlantic salmon.
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.